| Patent | Date |
|---|
Method of treating a localized fibrotic disorder using an IL-33 antagonist
Grant 11,400,154 - Larsen , et al. August 2, 2 | 2022-08-02 |
Method of Treating Dupuytren's Disease Using A Pre-filled Syringe
App 20220235125 - Nanchahal; Jagdeep ; et al. | 2022-07-28 |
Methods For Reducing Post-operative Cognitive Dysfunction (pocd)
App 20220112281 - Maze; Mervyn ; et al. | 2022-04-14 |
Prophylactic And Therapeutic Uses Of Fully Reduced Forms Of Hmgb1 In Conditions Involving Organs
App 20220023387 - Nanchahal; Jagdeep ; et al. | 2022-01-27 |
Methods for reducing post-operative cognitive dysfunction (POCD)
Grant 11,220,540 - Maze , et al. January 11, 2 | 2022-01-11 |
Method Of Treating A Localized Fibrotic Disorder Using A Tnf Receptor 2 Antagonist
App 20210386855 - Larsen; Glenn ; et al. | 2021-12-16 |
Method And System For Improving The Greenhouse Gas Emission Reduction Performance Of Biogenic Fuels, Heating Mediums And Combustion Materials And/or For Enriching Agricultural Areas With Carbon-containing Humus
App 20210285017 - Feldmann; Marc ; et al. | 2021-09-16 |
Prophylactic Uses Of Partially Or Fully Reduced Forms Of Hmgb1 Prior To Injury
App 20210260157 - Nanchahal; Jagdeep ; et al. | 2021-08-26 |
Method Of Treating A Localized Fibrotic Disorder Using An Il-33 Antagonist
App 20200338193 - Larsen; Glenn ; et al. | 2020-10-29 |
Method For Preventing Or Reducing Post-operative Cognitive Dysfunction (pocd)
App 20200123245 - Maze; Mervyn ; et al. | 2020-04-23 |
Method of treating a localized fibrotic disorder using an IL-33 antagonist
Grant 10,500,273 - Larsen , et al. Dec | 2019-12-10 |
Method Of Treating Localized Fibrotic Disorders Using An Il-33/tnf Bispecific Antibody
App 20190225682 - Nanchahal; Jagdeep ; et al. | 2019-07-25 |
Method Of Treating Systemic Fibrotic Disorders Using An Il-33/tnf Bispecific Antibody
App 20190202907 - Nanchahal; Jagdeep ; et al. | 2019-07-04 |
Method Of Treating A Localized Fibrotic Disorder Using A Tnf Receptor 2 Antagonist
App 20180036404 - Larsen; Glenn ; et al. | 2018-02-08 |
Method Of Treating A Localized Fibrotic Disorder Using An Il-33 Antagonist
App 20180030130 - Larsen; Glenn ; et al. | 2018-02-01 |
Treatment And Screening
App 20140030218 - Udalova; Irina Alexandrovna ; et al. | 2014-01-30 |
Agonists Of Toll Like Receptor For Treating Cardiovasuclar Disease And Obesity
App 20140005255 - Monaco; Claudia ; et al. | 2014-01-02 |
TNF-alpha ANTAGONISTS AND METHOTREXATE IN THE TREATMENT OF TNF-MEDIATED DISEASE
App 20130064816 - Feldmann; Marc ; et al. | 2013-03-14 |
Concomitant treatment of rheumatoid arthritis with anti-TNF-alpha antibodies and methotrexate
Grant 8,383,120 - Feldmann , et al. February 26, 2 | 2013-02-26 |
Concomitant treatment of rheumatoid arthritis with anti-TNF-.alpha. antibodies and methotrexate
Grant 8,298,537 - Feldmann , et al. October 30, 2 | 2012-10-30 |
TNF-alpha Antagonists and Methotrexate in the Treatment of TNF-Mediated Disease
App 20120141475 - Feldmann; Marc ; et al. | 2012-06-07 |
TNF-alpha Antagonists and Methotrexate in the Treatment of TNF-Mediated Disease
App 20120141474 - Feldmann; Marc ; et al. | 2012-06-07 |
TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease
App 20110123543 - Feldmann; Marc ; et al. | 2011-05-26 |
Small molecular weight TNF receptor multimeric molecule
App 20110098226 - Chernajovsky; Yuti ; et al. | 2011-04-28 |
Activation and inhibition of the immune system
Grant 7,915,009 - Foxwell , et al. March 29, 2 | 2011-03-29 |
TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease
App 20110014188 - Feldmann; Marc ; et al. | 2011-01-20 |
Methods of treating rheumatoid arthritis with an anti-TNF-alpha antibodies and methotrexate
Grant 7,846,442 - Feldmann , et al. December 7, 2 | 2010-12-07 |
Methods of treating rheumatoid arthritis with p75 TNF-alpha receptor and methotrexate
Grant 7,838,489 - Feldmann , et al. November 23, 2 | 2010-11-23 |
Methods for enhancing antigen presentation
Grant 7,651,857 - Foxwell , et al. January 26, 2 | 2010-01-26 |
Methods of preventing or treating thrombosis with tumor necrosis factor antagonists
Grant 7,608,262 - Elliott , et al. October 27, 2 | 2009-10-27 |
Methods of preventing or treating cardiovascular, cerebrovascular and thrombotic disorders with tumor necrosis factor antagonists
App 20090263388 - Elliott; Michael J. ; et al. | 2009-10-22 |
TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease
App 20090175859 - Feldmann; Marc ; et al. | 2009-07-09 |
Method of identifying a compound that selectively inhibits cytokine-stimulated T cell induced production of TNF-alpha by monocytes
Grant 7,390,630 - Brennan , et al. June 24, 2 | 2008-06-24 |
Activation and inhibition of the immune system
App 20080124322 - Foxwell; Brian ; et al. | 2008-05-29 |
Suppression of TNFalpha and IL-12 in therapy
App 20070178099 - Feldmann; Marc ; et al. | 2007-08-02 |
Small molecular weight TNF receptor multimeric molecule
App 20070031925 - Chernajovsky; Yuti ; et al. | 2007-02-08 |
Small molecular weight TNF receptor multimeric molecule
Grant 7,070,783 - Chernajovsky , et al. July 4, 2 | 2006-07-04 |
Compositions and methods for treating rage-associated disorders
App 20060140933 - Pittman; Debra D. ; et al. | 2006-06-29 |
TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease
App 20060099212 - Feldmann; Marc ; et al. | 2006-05-11 |
Methods for inducing an immune response with an elevated th1/th2 ratio, by intracellular induction of nfkappab
App 20040241152 - Foxwell, Brian Maurice John ; et al. | 2004-12-02 |
Treatment of tumor necrosis factor-mediated diseases
App 20040228863 - Feldmann, Marc ; et al. | 2004-11-18 |
TNF.alpha. antagonists and cyclosporin in therapy of rheumatoid arthritis
Grant 6,770,279 - Feldmann , et al. August 3, 2 | 2004-08-03 |
Methods
App 20040086516 - Foxwell, Brian Maurice John ; et al. | 2004-05-06 |
Activation and inhibition of the immune system
App 20030153518 - Foxwell, Brian ; et al. | 2003-08-14 |
Multiple administrations of anti-TNF antibody
App 20030064070 - Feldmann, Marc ; et al. | 2003-04-03 |
Viral infection of cells
App 20020177572 - Feldmann, Marc ; et al. | 2002-11-28 |
Anti-TNF antibodies and methotrexate in the treatment of autoimmune disease
App 20020136723 - Feldmann, Marc ; et al. | 2002-09-26 |
Methods Of Preventing Or Treating Cardiovascular, Cerebrovascular And Thrombotic Disorders With Tumor Necrosis Factor Antagonists
App 20020081306 - ELLIOTT, MICHAEL J. ; et al. | 2002-06-27 |
Use of cannabinoids as anti-inflammatory agents
Grant 6,410,588 - Feldmann , et al. | 2002-06-25 |
Treatment Of Autoimmune And Inflammatory Disorders
App 20020068057 - FELDMANN, MARC ; et al. | 2002-06-06 |
Compositions, kits, and methods for identification and modulation of T helper-1 and T helper-2 cells and diseases associated therewith
App 20020039734 - Hanrahan, Catherine F. ; et al. | 2002-04-04 |
TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease
App 20020010180 - Feldmann, Marc ; et al. | 2002-01-24 |
Method for treating multiple sclerosis
Grant 5,958,409 - Turk , et al. September 28, 1 | 1999-09-28 |
Nucleic acid encoding modified human tnf.alpha. (tumor necrosis factor alpha) receptor
Grant 5,863,786 - Feldmann , et al. January 26, 1 | 1999-01-26 |
TNF.alpha. receptor-derived binding protein
Grant 5,633,145 - Feldmann , et al. May 27, 1 | 1997-05-27 |
| 